ReleaseWire

"Global Allergic Rhinitis Drugs Market 2016-2020" Published

Fast Market Research announces the availability of the new TechNavio report, "Global Allergic Rhinitis Drugs Market 2016-2020", on their comprehensive research portal

Posted: Tuesday, March 01, 2016 at 8:11 AM CST

Boston, MA -- (SBWire) -- 03/01/2016 --Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE) type antibodies on the surface of mast cells. This interaction causes mast cells to release and synthesize chemicals, causing inflammation of the surrounding tissues. Typical symptoms include rhinorrhea, nasal itching, sneezing, and nasal congestion. Extranasal symptoms such as allergic conjunctivitis, itchy ears and palate, and asthma may also occur. Allergic rhinitis is treated using medications such as antihistamines, intranasal corticosteroids, or immunotherapies. Alternative forms of treatment are also employed in certain cases.

Technavio's analysts forecast the global allergic rhinitis market to grow at a CAGR of 0.95% during the period 2016-2020.

Get More Details on this Report and a Full Table of Contents at Global Allergic Rhinitis Drugs Market 2016-2020

Covered in this report
The report covers the present scenario and the growth prospects of the global allergic rhinitis drugs market for the period 2016-2020. To calculate the market size, it considers revenue generated from the sales of prescription and off-label drugs used to treat allergic rhinitis.

The market is divided into the following segments based on geography:

-Americas
-APAC
-Europe

Technavio's report, Global Allergic Rhinitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-AstraZeneca
-GlaxoSmithKline
-Meda Pharmaceuticals
-Merck
-Sanofi
-UCB

Other prominent vendors

-Adamis Pharmaceuticals
-Alcon
-Alergo Pharma
-ALK-Abello
-Allergy Therapeutics
-Almirall
-Ampio
-Anergis
-Apotex
-Ares Life Sciences
-Array BioPharma
-Aspen Pharmacare
-Atopix Therapeutics
-Barr Laboratories
-Belcher Pharmaceuticals
-Circassia Pharmaceuticals
-Dainippon Sumitomo
-DBV Technologies
-Dr Reddy's Laboratories
-Eddingpharm
-Genentech
-Greer Laboratories
-Hanmi Pharmaceuticals
-Hisamitsu Pharmaceutical
-Intas Pharmaceuticals
-Kyowa Hakko
-Lupin Pharmaceuticals
-Mitsubishi Tanabe Pharma
-Mylan
-Nektar Therapeutics
-Novartis
-Nuvo Research
-Nycomed
-Omega Pharma
-Ono Pharmaceuticals
-Pfizer
-Revance Therapeutics
-Roxane Laboratories (Boehringer Ingelheim)
-Shionogi
-Stallergenes
-Sun Pharmaceuticals
-Takeda Pharmaceutical
-Teva Pharmaceuticals
-Verona Pharma
-VentiRx Pharmaceuticals

Market driver

-Increased prevalence of allergic rhinitis
-For a full, detailed list, view our report

Market challenge

-Patent expiries and competition from generic drugs
-For a full, detailed list, view our report

Market trend

-Increased R&D
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2020 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: AstraZeneca, GlaxoSmithKline, Meda Pharmaceuticals, Merck, Sanofi, UCB, Adamis Pharmaceuticals, Alcon, Alergo Pharma, ALK-Abello, Allergy Therapeutics, Almirall, Ampio, Anergis, Apotex, Ares Life Sciences, Array BioPharma, Aspen Pharmacare, Atopix Therapeutics, Barr Laboratories, Belcher Pharmaceuticals, Circassia Pharmaceuticals, Dainippon Sumitomo, DBV Technologies, Dr Reddy's Laboratories, Eddingpharm, Genentech, Greer Laboratories, Hanmi Pharmaceuticals, Hisamitsu Pharmaceutical, Intas Pharmaceuticals, Kyowa Hakko, Lupin Pharmaceuticals, Mitsubishi Tanabe Pharma, Mylan, Nektar Therapeutics, Novartis, Nuvo Research, Nycomed, Omega Pharma, Ono Pharmaceuticals, Pfizer, Revance Therapeutics, Roxane Laboratories (Boehringer Ingelheim), Shionogi, Stallergenes, Sun Pharmaceuticals, Takeda, Teva Pharmaceuticals, Verona Pharma, VentiRx Pharmaceuticals

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:
-PharmaPoint: Allergic Rhinitis - Global Drug Forecast and Market Analysis to 2024
-Allergic Rhinitis - Pipeline Review, H1 2015
-Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2015
-Global Preventive Asthma Drugs Market 2015-2019
-Global Acne Drugs Market 2016-2020